top of page
IGT Congressional Letter and Statement on the Re-Introduction of the MVP Act (H.R. 2666)
Today, the Institute for Gene Therapies (IGT) sent a letter to Congress applauding Representatives Brett Guthrie (R-KY), Anna Eshoo...
Perspective: Advancing Hope for Andrew and Countless Others
By Nate Plasman This February, I had the opportunity to travel to Capitol Hill to participate in the Institute for Gene Therapy’s...

Our Healthcare Policies Must Account for the True Value of Transformative Gene Therapies
By IGT Chairman Erik Paulsen As more breakthrough gene therapies are developed and brought to market, a critical element in bringing...


Congressional Briefing: Realizing the Promise of Gene Therapy through Science & Policy
On February 21, the Institute for Gene Therapies hosted a panel discussion on the science of gene therapy, its impact on patients and...
ICYMI: Cure Sickle Cell Disease by 2030?
IGT Scientific, Academic, and Medical Council Chair Dr. Donna Christian-Christensen recently wrote an opinion piece for Inside Sources,...


A Bold Goal to Cure Sickle Cell Disease by 2030
By IGT Scientific, Academic & Medical Advisory Council Chair Donna M. Christensen Last week, during the Congressional Black Caucus...
IGT Comments on CMS Fiscal Year 2023 Medicare Inpatient Prospective Payment Systems Proposed Rule
Earlier this month the Institute for Gene Therapies submitted a comment letter to the Centers for Medicare and Medicaid Services (CMS) on...
New Resource: Understanding the Complexity of Gene Therapy Science & Manufacturing
Gene therapies present a unique opportunity to change the way we treat diseases. Given the complex nature of these transformative...

IGT Chairman Erik Paulsen Joins Healthy Future Task Force Treatments Subcommittee Roundtable
On April 28th, IGT Chairman Paulsen joined leaders in Congress on the Healthy Future Task Force Treatments Subcommittee Roundtable. The...

A Troubling Policy Proposal
Last week, IGT joined many organizations in expressing concern about a policy proposal that would restrict patients’ access to certain...
bottom of page